Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gemma Arranz de la Mata"'
Autor:
Antonio Roman, Teresa Angueira Lapeña, Jaime Masjuan Vallejo, Gemma Arranz de la Mata, Gema de la Poza Gómez, Daniel Boixeda de Miquel
Publikováno v:
Gastroenterología y Hepatología. 32:343-345
We report the case of a female patient who was diagnosed with Vogt-Koyanagi-Harada disease at the age of 14 years and who developed myelopathy, resulting in paraparesis. A cerebral magnetic resonance imaging scan revealed the presence of T2-hyperinte
Autor:
Miguel Rivero Fernández, Gemma Arranz de la Mata, Daniel Boixeda de Miquel, Manuel Vázquez Romero, Teresa Angueira Lapeña, Gema de la Poza Gómez
Publikováno v:
Gastroenterología y Hepatología. 31:643-645
Metformin is an oral antidiabetic agent frequently used to manage type II diabetes. This drug produces nonspecific gastrointestinal symptoms in 5-20% of patients and, more rarely, has also been associated with severe adverse effects such as lactic ac
Autor:
Gema, de la Poza Gómez, Antonio, López-San Román, Jaime, Masjuan Vallejo, Gemma, Arranz de la Mata, Teresa, Angueira Lapeña, Daniel, Boixeda de Miquel
Publikováno v:
Gastroenterologia y hepatologia. 32(5)
We report the case of a female patient who was diagnosed with Vogt-Koyanagi-Harada disease at the age of 14 years and who developed myelopathy, resulting in paraparesis. A cerebral magnetic resonance imaging scan revealed the presence of T2-hyperinte
Autor:
Gema, de la Poza Gómez, Miguel, Rivero Fernández, Manuel, Vázquez Romero, Teresa, Angueira Lapeña, Gemma, Arranz de la Mata, Daniel, Boixeda de Miquel
Publikováno v:
Gastroenterologia y hepatologia. 31(10)
Metformin is an oral antidiabetic agent frequently used to manage type II diabetes. This drug produces nonspecific gastrointestinal symptoms in 5-20% of patients and, more rarely, has also been associated with severe adverse effects such as lactic ac